Abstract:Cell-based therapy holds great promise for cancer treatment. The ability to non-invasively track the delivery of various therapeutic cells (e.g. T cells and stem cells) to the tumor site, and/or subsequent differentiation/proliferation of these cells, would allow better understanding of the mechanisms of cancer development and intervention. This brief review will summarize the various methods for non-invasive cell tracking in cancer and cancer therapy. In general, there are two approaches for cell tracking: direct (cells are labeled with certain tags that can be detected directly with suitable imaging equipment) and indirect cell labeling (which typically uses reporter genes approach). The techniques for tracking various cell types (e.g. immune cells, stem cells, and cancer cells) in cancer are described, which include fluorescence, bioluminescence, positron emission tomography (PET), single-photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI). Non-invasive tracking of immune and stem cells were primarily intended for (potential) cancer therapy applications while tracking of cancer cells could further our understanding of cancer development and tumor metastasis. Safety is a major concern for future clinical applications and the ideal imaging modality for tracking therapeutic cells in cancer patients requires the imaging tags to be non-toxic, biocompatible, and highly specific. Each imaging modality has its advantages and disadvantages and they are more complementary than competitive. MRI, radionuclide-based imaging techniques, and reporter gene-based approaches will each have their own niches towards the same ultimate goal: personalized medicine for cancer patients. Keywords: Cancer, cell tracking, cancer therapy, stem cells, positron emission tomography, molecular imaging, optical imaging, magnetic resonance imaging

Advances in tracking immunocytes using cellular magnetic resonance imaging in vivo

A primer on in vivo cell tracking using MRI

In vivo imaging platform for tracking immunotherapeutic cells

Non-invasive Cell Tracking in Cancer and Cancer Therapy.

The Development of Cell Tracking Technology

Using MRI cell tracking to monitor immune cell recruitment in response to a peptide-based cancer vaccine

Tracking the fates of iron-labeled tumor cells in vivo using Magnetic Particle Imaging

Molecular Imaging in Tracking Tumor Stem-Like Cells

In Vivo Magnetic Resonance Imaging of CD8+ T Lymphocytes Recruiting to Glioblastoma in Mice

In Vivo Cellular Magnetic Imaging: Labeled versus Unlabeled Cells (Adv. Funct. Mater. 50/2022)

Noninvasive strategies of cell-tracking in vivo

High-efficiency magnetophoretic labelling of adoptively-transferred T cells for longitudinal in vivo Magnetic Particle Imaging

Immune cell labelling and tracking: implications for adoptive cell transfer therapies

Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response

In Vivo Magnetic Resonance Tracking of Magnetically Labeled Cells after Transplantation

Research progress in the molecular imaging tracking of cancer stem cells in vivo

Improving Tumor Retention of Effector Cells in Adoptive Cell Transfer Therapies by Magnetic Targeting

Cellular Magnetic Resonance Imaging: in Vivo Tracking of Gastric Cancer Cells and Detecting of Lymph Node Metastases Using Microparticles of Iron Oxide in Mice

Dual Contrast Magnetic Resonance Imaging Tracking of Iron-Labeled Cells in Vivo

Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring

New Advancements in the Enrichment of Circulating Tumor Cells by Immunomagnetic Beads